These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9610690)

  • 21. Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.
    Tecimer C; Doering DL; Goldsmith LJ; Meyer JS; Abdulhay G; Wittliff JL
    Gynecol Oncol; 2001 Jan; 80(1):48-55. PubMed ID: 11136569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.
    Yonemura Y; Endo Y; Fujita H; Fushida S; Ninomiya I; Bandou E; Taniguchi K; Miwa K; Ohoyama S; Sugiyama K; Sasaki T
    Clin Cancer Res; 1999 Jul; 5(7):1823-9. PubMed ID: 10430087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
    Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
    Champelovier P; Boucard N; Levacher G; Simon A; Seigneurin D; Praloran V
    Urol Res; 2002 Oct; 30(5):301-9. PubMed ID: 12389118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between overexpression of c-met gene and the progression of gastric cancer.
    Yonemura Y; Kaji M; Hirono Y; Fushida S; Tsugawa K; Fujimura T; Miyazaki I; Harada S; Yamamoto H
    Int J Oncol; 1996 Mar; 8(3):555-60. PubMed ID: 21544396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
    Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
    BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
    Dohn LH; Illemann M; Høyer-Hansen G; Christensen IJ; Hostmark J; Litlekalsoy J; von der Maase H; Pappot H; Laerum OD
    Urol Oncol; 2015 Apr; 33(4):165.e15-24. PubMed ID: 25575713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
    Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
    Kara M; Ohta Y; Tanaka Y; Oda M; Watanabe Y
    Ann Thorac Surg; 2001 Mar; 71(3):944-8. PubMed ID: 11269478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue urokinase-type plasminogen activator receptor levels in breast cancer.
    Gong SJ; Rha SY; Chung HC; Yoo NC; Roh JK; Yang WI; Lee KS; Min JS; Kim BS; Chung HC
    Int J Mol Med; 2000 Sep; 6(3):301-5. PubMed ID: 10934293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
    Hirono Y; Fushida S; Yonemura Y; Yamamoto H; Watanabe H; Raz A
    Br J Cancer; 1996 Dec; 74(12):2003-7. PubMed ID: 8980404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
    Nakajima M; Sawada H; Yamada Y; Watanabe A; Tatsumi M; Yamashita J; Matsuda M; Sakaguchi T; Hirao T; Nakano H
    Cancer; 1999 May; 85(9):1894-902. PubMed ID: 10223227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma.
    Alpízar-Alpízar W; Christensen IJ; Santoni-Rugiu E; Skarstein A; Ovrebo K; Illemann M; Laerum OD
    Int J Cancer; 2012 Aug; 131(4):E329-36. PubMed ID: 21901747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase-type plasminogen activator receptor expression in adenoid cystic carcinoma of the skull base.
    Doerr TD; Marentette LJ; Flint A; Elner V
    Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):215-8. PubMed ID: 12578452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
    Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
    Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.